GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DRI Healthcare Trust (TSX:DHT.U) » Definitions » Buyback Yield %

DRI Healthcare Trust (TSX:DHT.U) Buyback Yield % : 0.89 (As of Apr. 18, 2025)


View and export this data going back to 2021. Start your Free Trial

What is DRI Healthcare Trust Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

DRI Healthcare Trust's current buyback yield was 0.89%.


DRI Healthcare Trust Buyback Yield % Historical Data

The historical data trend for DRI Healthcare Trust's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DRI Healthcare Trust Buyback Yield % Chart

DRI Healthcare Trust Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Buyback Yield %
-194.51 3.38 -27.96 0.84

DRI Healthcare Trust Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.96 -23.06 -23.24 0.72 0.84

Competitive Comparison of DRI Healthcare Trust's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, DRI Healthcare Trust's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DRI Healthcare Trust's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DRI Healthcare Trust's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where DRI Healthcare Trust's Buyback Yield % falls into.


;
;

DRI Healthcare Trust Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

DRI Healthcare Trust's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-3.917 + 0) / 465.07104
=0.84%

DRI Healthcare Trust's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (-3.917 + 0) / 465.07104
=0.84%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .


DRI Healthcare Trust Buyback Yield % Related Terms

Thank you for viewing the detailed overview of DRI Healthcare Trust's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


DRI Healthcare Trust Business Description

Traded in Other Exchanges
Address
100 King Street West, 1 First Canadian Place, Suite 7250, Toronto, ON, CAN, M5X 1B1
DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. The Trust has concluded that it operates as one segment, focused on acquiring royalty assets. Geographically the trust generates it's key revenue from the United States. The trust also generates Income from markets such as Japan, and the European Union.

DRI Healthcare Trust Headlines

No Headlines